Mrs. Chetna re-appointed as Independent Director for 5-year term

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.1%Reaction day

₹41.05

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-0.8% vs market

Pharmaceuticals peers, median of 173sector-0.8%-1.3% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.1-1.3-0.8-0.8-1.3

Next day

-4.1-1.3-2.8-1.2-2.8

-6.0+0.0-6.0-0.4-5.6

-7.8-0.2-7.6-0.1-7.7

-9.7-3.0-6.7-3.0-6.6

-11.5-2.7-8.8-3.1-8.4

-20.1-1.7-18.4-3.0-17.0

15d

-21.6-8.9-12.7-6.9-14.6

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Members of ANG Lifesciences India Limited at the 20th AGM approved the re-appointment of Mrs. Chetna (DIN: 08981045) as Independent Director for a second term of five years, from October 12, 2026 to October 11, 2031. She holds an LLB, CS, and MBA (Finance), with experience in corporate law, securities law, SEBI compliance, financial management, and taxation.

Likely market impact

Routine re-appointment of existing independent director. No immediate impact on stock or shareholders expected.